全球百日咳疫苗市場規模（按疫苗類型、年齡層、分銷管道、區域覆蓋範圍和預測）

百日咳疫苗市場規模及預測

百日咳疫苗市場規模在 2023 年價值 86.1277 億美元，預計到 2032 年將達到 154.2981 億美元，預測期內（2026-2032 年）的複合年成長率為 8.34%。

推動全球百日咳疫苗市場的因素

百日咳疫苗市場的市場驅動力可能受到多種因素的影響，其中包括：

百日咳發病率不斷上升：百日咳疫情：百日咳疫情，也稱為百日咳，繼續在世界各地肆虐，越來越需要接種疫苗來阻止疾病的傳播。

政府措施和疫苗接種計劃許多政府和醫療保健組織積極推廣百日咳疫苗接種作為常規免疫計劃的一部分，包括針對嬰兒、幼兒、青少年和成人的計劃，有助於擴大該行業。

疫苗技術發展：由於疫苗研究技術的進步，百日咳疫苗接種正變得越來越新，也越來越安全。這些發展是研發資金的驅動力。

教育和宣傳宣傳活動：透過教育計畫和宣傳活動提高大眾對百日咳疫苗接種價值的認知，對於增加需求至關重要。公眾和醫護人員意識的提高將有助於提高疫苗接種率。

醫療保健支出不斷增加：百日咳疫苗市場因醫療保健支出不斷增加而不斷成長，尤其是預防保健支出，其中包括疫苗宣傳活動資金和疫苗分發所需的基礎設施。

兒童疫苗接種興趣日益成長：隨著人們對兒科醫療保健以及新生兒和兒童健康的日益關注，預計百日咳疫苗的需求將持續成長。百日咳疫苗通常被納入小兒科疫苗接種計劃，這推動了市場的成長。

全球化與旅行：便捷的全球旅行增加了百日咳等疾病傳播的風險。百日咳特別流行的地區已經頒布了針對旅行者的疫苗接種法律，這促進了該行業的發展。

夥伴關係與協作：醫療保健提供者、政府機構、非營利組織和疫苗製造商之間的這些夥伴關係與協作正在透過促進疫苗的取得、分發和可負擔性來幫助市場成長。

限制全球百日咳疫苗市場的因素

百日咳疫苗市場可能面臨多種限制與挑戰，包括：

知識和途徑有限：在某些地區，特別是在低收入和偏遠社區，人們對百日咳疫苗接種的了解有限，並且無法獲得提供疫苗接種服務的醫療保健提供者的幫助，這可能會限制疫苗接種工作並阻礙市場擴張。

疫苗接種費用：百日咳疫苗接種費用可能是一個主要障礙，尤其是對於沒有保險或在私人醫療機構就診的人而言。這可能會導致部分人口因經濟困難而無法接種疫苗，從而阻礙市場擴張。

疫苗分發和儲存挑戰：百日咳疫苗通常需要特殊的儲存條件，例如冷藏，這在物流方面可能具有挑戰性，尤其是在農村和人口稀少的地區。維護低溫運輸會增加整個過程的複雜性和成本。

疫苗厭惡和安全疑慮：與任何醫療程序一樣，疫苗接種可能會引起某些人群和群體的安全疑慮。資訊不準確以及對醫療保健提供者缺乏信任可能會導致人們猶豫接種疫苗，從而阻礙市場成長並降低疫苗接種率。

監管障礙：不同國家和地區對疫苗分銷和批准的規定各不相同。疫苗製造商可能難以遵守嚴格的臨床試驗和生產流程規定，這可能會阻礙疫苗的成長和進入新市場。

競爭環境：百日咳疫苗市場存在多家疫苗生產商，競爭激烈，可能導致定價壓力和利潤率下降。企業可能難以有效地實現產品差異化並搶佔市場佔有率。

公共衛生政策與資金籌措：百日咳疫苗接種需求可能會受到公共衛生政策變化、政府免疫計畫資金籌措變化以及醫療保健預算波動的影響。長期資金籌措和政策變化的不確定性可能會導致市場波動。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

4. 百日咳疫苗市場（依疫苗類型）

• 全細胞百日咳疫苗
• 無細胞百日咳疫苗

第5章百日咳疫苗市場（依年齡層）

• 嬰兒
• 孩子們
• 成人

6. 百日咳疫苗市場（依分銷管道）

• 醫院和診所
• 零售藥局
• 網路藥局

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• Kubota
• Deluxe Agro Industries
• AGCO
• Bharat Industries
• Iseki & Co
• ALMACO
• Alvan Blanch
• Wuhan Acme Agro Tech.
• GlaxoSmithKline
• Sanofi Pasteur
• Pfizer Inc.
• Serum Institute of India Pvt Ltd

第11章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Pertussis Vaccine Market Size And Forecast

Pertussis Vaccine Market size was valued at USD 8612.77 Million in 2023 and is projected to reach USD 15429.81 Million by 2032, growing at a CAGR of 8.34% during the forecast period 2026-2032.

Global Pertussis Vaccine Market Drivers

The market drivers for the Pertussis Vaccine Market can be influenced by various factors. These may include:

Growing Incidence of Pertussis: The market is significantly influenced by the growing prevalence of pertussis, also known as whooping cough. The necessity for immunisation to stop the disease's spread is growing as it continues to harm people all over the world.

Government Initiatives and Immunisation Programmes: As part of regular vaccination schedules, a number of governments and healthcare organisations are actively promoting immunisation against pertussis. Programmes aimed for babies, kids, teens, and adults are included in this, which helps the industry expand.

Technological Developments in Vaccines: Newer and safer pertussis vaccinations have been made possible by technological advancements in vaccine research. Growth in the market is fueled by these developments, which draw funding for R&D.

Education and Public Awareness Campaigns: Raising public awareness of the value of the pertussis vaccination through educational programmes and campaigns is essential to increasing demand. Vaccine uptake is boosted by greater awareness among the general public and healthcare professionals.

Increase in Healthcare Spending: The market for pertussis vaccine is growing as a result of the general increase in healthcare spending, especially in preventative healthcare measures. This covers funding for immunisation campaigns and the infrastructure needed to distribute vaccines.

Growing Interest in Paediatric Vaccination: There will likely be a continued high demand for pertussis vaccines due to the increased attention being paid to paediatric healthcare and the health of newborns and children. Pertussis vaccine is frequently included in paediatric vaccination schedules, which is fueling market expansion.

Globalisation and Travel: The ease with which people can travel the world has raised the possibility of spreading diseases, such as pertussis. Traveller vaccination laws, particularly in areas where pertussis is more common, aid in the growth of the industry.

Partnerships and Collaborations: These partnerships and collaborations assist market growth by facilitating vaccine access, distribution, and affordability between healthcare providers, government agencies, non-profit organisations, and vaccine makers.

Global Pertussis Vaccine Market Restraints

Several factors can act as restraints or challenges for the Pertussis Vaccine Market. These may include:

Limited Knowledge and Access: There may be limited knowledge about the pertussis vaccination in some areas, particularly in low-income or isolated communities, or there may be limited access to medical facilities that provide vaccination services. This may impede market expansion by limiting the reach of immunisation initiatives.

Vaccination expense: The expense of the pertussis vaccination can be a major obstacle, especially for people without insurance or in private healthcare settings. Affordability concerns could prevent some demographic segments from receiving vaccinations, which would hinder market expansion.

Difficulties with Vaccine Distribution and Storage: Pertussis vaccinations frequently need particular storage environments, such refrigeration, which can be logistically difficult, particularly in rural or underdeveloped locations. Keeping the cold chain intact increases the process's complexity and expense.

Vaccine Hesitancy and Safety worries: Similar to any medical procedure, vaccinations may cause certain people or groups to have safety worries. Inaccurate information or a lack of faith in medical institutions can cause vaccine hesitation, which can impede market growth and reduce immunisation rates.

Regulatory Obstacles: varied nations and areas have varied regulatory regulations for the distribution and licencing of vaccines. For vaccine producers, adhering to strict regulations on clinical studies and manufacturing procedures can be difficult, which might hinder their ability to enter and grow new markets.

Competitive Environment: There may be pressure on prices and lower profit margins due to the existence of several vaccine makers and competition in the Pertussis Vaccine Market. Businesses may encounter difficulties efficiently differentiating their products and gaining market share.

Public Health Policies and financing: The demand for pertussis vaccinations may be impacted by modifications to public health policies, changes in government financing for immunisation programmes, and variations in healthcare budgets. Market volatility may result from unclear long-term funding or policy changes.

Global Pertussis Vaccine Market Segmentation Analysis

The Global Pertussis Vaccine Market is Segmented on the basis of Type of Vaccine, Age Group, Distribution Channel, and Geography.

Pertussis Vaccine Market, By Type of Vaccine

• Whole-cell Pertussis Vaccines: These vaccines contain whole, killed Bordetella pertussis bacteria. They were the first type of pertussis vaccines developed and used widely in the past. However, they are associated with more side effects compared to acellular vaccines.
• Acellular Pertussis Vaccines: These vaccines contain purified components of the Bordetella pertussis bacteria, such as pertussis toxin, filamentous hemagglutinin, pertactin, and fimbriae. They are newer and generally have fewer side effects, making them preferred for routine immunization.

Pertussis Vaccine Market, By Age Group

• Infants: Pertussis vaccination in infants is crucial as they are more susceptible to severe complications of pertussis, such as pneumonia and seizures.
• Children: Continued vaccination during childhood ensures sustained protection against pertussis.
• Adults: Vaccination in adults, especially pregnant women and healthcare workers, helps prevent the transmission of pertussis to vulnerable populations.

Pertussis Vaccine Market, By Distribution Channel

• Hospitals and Clinics: These are primary channels for vaccination, especially for infants and children during routine healthcare visits.
• Retail Pharmacies: Increasingly important for adult vaccinations and convenience for individuals seeking booster doses.
• Online Pharmacies: Emerging as a convenient option for vaccine distribution, especially during the COVID-19 pandemic when remote access to healthcare services has become more prevalent.

Pertussis Vaccine Market, By Geography

• North America: Market conditions and demand in the United States, Canada, and Mexico.
• Europe: Analysis of the Pertussis Vaccine Market in European countries.
• Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa: Examining market dynamics in the Middle East and African regions.
• Latin America: Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Pertussis Vaccine Market are:
• Kubota
• Deluxe Agro Industries
• AGCO
• Bharat Industries
• Iseki & Co
• ALMACO
• Alvan Blanch
• Wuhan Acme Agro Tech.
• GlaxoSmithKline
• Sanofi Pasteur
• Pfizer Inc.
• Serum Institute of India Pvt Ltd

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Pertussis Vaccine Market, By Type of Vaccine

• Whole-cell Pertussis Vaccines
• Acellular Pertussis Vaccines

5. Pertussis Vaccine Market, By Age Group

• Infants
• Children
• Adults

6. Pertussis Vaccine Market, By Distribution Channel

• Hospitals and Clinics
• Retail Pharmacies
• Online Pharmacies

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Kubota
• Deluxe Agro Industries
• AGCO
• Bharat Industries
• Iseki & Co
• ALMACO
• Alvan Blanch
• Wuhan Acme Agro Tech.
• GlaxoSmithKline
• Sanofi Pasteur
• Pfizer Inc.
• Serum Institute of India Pvt Ltd

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References